The University of Miami Miller School of Medicine – UHealth is home to some of the brightest minds in the world. At the U, we are committed to attracting and retaining a talented workforce to support our common purpose of transforming lives through teaching, research, and service. Our Faculty teach students who represent the future of medicine.

General Information: Our researchers are discovering breakthrough patient treatments. As an academic medical center, we are proud to serve South Florida, Latin America and the Caribbean. Our physicians represent more than 100 specialties and subspecialties, and have more than one million patient encounters each year.

Organization: The Department of Biochemistry and Molecular Biology has an opportunity available for a Postdoctoral Associate. Dr. Feng-Chun Yang’s laboratory is focusing on understanding the cellular and molecular mechanisms mediating pathogenic development of hematopoietic malignancies.

Project information: Asxl1 gene is mutated and/or deleted with high frequencies in multiple forms of myeloid malignancies including MDS, MPN and AML. The majority of the ASXL1 mutations in these patients are heterozygous, leading to nonsense/frameshift, suggesting loss of function. Mutations in ASXL1 are associated with poor prognosis. We recently found that normal interaction of Asxl1 and BAP1 is required for the hematopoiesis. One of our projects is to clarify whether disruption of Asxl1/Bap1 interaction leads to myeloid malignancies. Candidate  will utilize murine models of Asxl1, Bap1 to characterize the phenotypes in various Asxl1- Bap1 deficient mice, including Asxl1+/- and Bap1f/f;MxCre or Vav1Cre mice. In addition,  the candidate will study the molecular mechanisms by which Asxl1-Bap1 interaction regulates normal hematopoiesis and exerts their tumor suppressor function in myelopoiesis. Furthermore, ChIP-Seq will be used to identify the differential genes targeted by Asxl1 and Bap1. Dr. Li will analyze Asxl1- and Bap1- associated histone H3 methylation and dissect co-deletion of Asxl1 and Bap1 induced misregulation of H3 methylation in HSCs.

Qualifications / requirements: Minimum qualifications include a PhD in a science related field. No experience necessary.  Any appropriate combination of education, certifications, and/or relevant work experience may be considered.

At the University of Miami School of Medicine, patient safety is a top priority.  As a result, during the Influenza (“the flu”) season (September through April),  the University of Miami School of Medicine requires all employees who provide ongoing services to patients, work in a location (all Hospitals and clinics) where patient care is provided, or work in patient care or clinical care areas, to have an annual influenza vaccination.

UHealth-University of Miami Health System, South Florida’s only university-based health system, provides leading-edge patient care powered by the groundbreaking research and medical education at the Miller School of Medicine. University of Miami Hospital is the flagship facility of UHealth, which also includes the Sylvester Comprehensive Cancer Center and Bascom Palmer Eye Institute, along with dozens of outpatient facilities. Our tradition of excellence has earned worldwide recognition for outstanding teaching, research and patient care. We’re the challenge you’ve been looking for.

Follow us on  Twitter @univmiamijobs

The University of Miami is an Equal Opportunity Employer – Females/Minorities/Protected Veterans/Individuals with Disabilities are encouraged to apply.

Deadline: not mentioned